Abstract CT116: Preclinical antitumor activity and first-in-human phase I study of NB004/GDC-0570, a novel pan-PIM kinase inhibitor, in patients with advanced solid tumors

已取消 10 由小小发布于 2025/2/6 11:18:48

DOI:10.1158/1538-7445.am2024-ct116
作者：Siqing Fu, R. Sanborn, Minxia Cai, Lijia Zhang, Yanhua Xu, Kui Lin
文献类型：期刊论文
补充材料：只需要正文
管理员驳回:超时未应助，系统关闭。如求助信息不完整（标题、DOI、原文链接），可以补充后重新发布求助。

American Association for Cancer Research (AACR)

Abstract： PIM proto-oncogenes encode a family of three serine/threonine kinases (PIM1, PIM2, PIM3), which are frequently overexpressed in human hematological malignancies and solid cancers. PIM kina

应助信息

2025-02-06

Book学术机器人

2025/2/6 11:18:48 未找到该文献，机器人已退出，请等待人工下载

2025/2/6 11:18:48 Book学术AI机器人收到请求，开始寻找文献

2025/2/6 11:18:48 已向机器人发送请求

2025-02-06

小小发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Association for Cancer Research (AACR)The Journey of Antibody-Drug Conjugates: Lessons Learned from 40 Years of Development.